Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: AEE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on AEE, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 1,285,233 AEE shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,285,233 shares
    Change vs previous 13F +13,647 shares

    2.66% of the 13F portfolio, value $145,282,738.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,271,586 shares
    Change vs previous 13F +28,095 shares

    2.69% of the 13F portfolio, value $139,772,733.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,243,491 shares
    Change vs previous 13F -127,267 shares

    2.61% of the 13F portfolio, value $124,184,322.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,370,758 shares
    Change vs previous 13F +1,369,450 shares

    3.21% of the 13F portfolio, value $143,090,514.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,308 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $125,630.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,308 shares
    Change vs previous 13F -891 shares

    <0.01% of the 13F portfolio, value $131,334.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,199 shares
    Change vs previous 13F -1,262,004 shares

    0.01% of the 13F portfolio, value $196,035.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,264,203 shares
    Change vs previous 13F not available

    3.83% of the 13F portfolio, value $110,575,163.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).